15-[4-(trifluoromethyl)phenyl]-8,11-dithia-15-azatetracyclo[7.6.0.02,7.010,14]pentadeca-1(9),2,4,6,10(14),12-hexaene
C19H10F3NS2 — CID 170972421
Data last refreshed: (MolForge compound catalog, from PubChem)
About 15-[4-(trifluoromethyl)phenyl]-8,11-dithia-15-azatetracyclo[7.6.0.02,7.010,14]pentadeca-1(9),2,4,6,10(14),12-hexaene
15-[4-(trifluoromethyl)phenyl]-8,11-dithia-15-azatetracyclo[7.6.0.02,7.010,14]pentadeca-1(9),2,4,6,10(14),12-hexaene (PubChem CID 170972421) has the molecular formula C19H10F3NS2 and a molecular weight of 373.42 g/mol. Its IUPAC name is 15-[4-(trifluoromethyl)phenyl]-8,11-dithia-15-azatetracyclo[7.6.0.02,7.010,14]pentadeca-1(9),2,4,6,10(14),12-hexaene.
Molecular Properties
| Compound Name | 15-[4-(trifluoromethyl)phenyl]-8,11-dithia-15-azatetracyclo[7.6.0.02,7.010,14]pentadeca-1(9),2,4,6,10(14),12-hexaene |
|---|---|
| PubChem CID | 170972421 |
| Molecular Formula | C19H10F3NS2 |
| Molecular Weight | 373.42 g/mol |
| Exact Mass | 373.02 |
| IUPAC Name | 15-[4-(trifluoromethyl)phenyl]-8,11-dithia-15-azatetracyclo[7.6.0.02,7.010,14]pentadeca-1(9),2,4,6,10(14),12-hexaene |
| SMILES | FC(F)(F)c1ccc(-n2c3ccsc3c3sc4ccccc4c32)cc1 |
| InChI | InChI=1S/C19H10F3NS2/c20-19(21,22)11-5-7-12(8-6-11)23-14-9-10-24-17(14)18-16(23)13-3-1-2-4-15(13)25-18/h1-10H |
| InChIKey | TZMCJJOHXBQKEE-UHFFFAOYSA-N |
| XLogP | 7.08 |
| TPSA | 4.93 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 373.42 |
| LogP ≤ 5 | 7.08 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170972421 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.